Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Pediatrics - United States
doi 10.1542/peds.2018-2420ccc
Full Text
Open PDFAbstract
Available in full text
Date
November 30, 2018
Authors
Publisher
American Academy of Pediatrics (AAP)